Investing

DryShips, Agile Therapeutics in Wednesday's 52-Week Low Club

January 4, 2017: Here are three stocks trading with relatively heavy volume among 17 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by nearly 6 to 1 and on the Nasdaq advancers led decliners by nearly about the same margin. Total volume reached about 10% higher than the daily average.

Agile Therapeutics Inc. (NASDAQ: AGRX) dropped nearly 64% on Wednesday to post a new 52-week low of $1.82 after closing at $5.00 on Tuesday. Volume was more than 100 times the daily average of just 100,000 shares. The company’s reported positive results for its contraceptive patch, but a high number of patients dropped out of the study and an FDA review is virtually certain.

DryShips Inc. (NASDAQ: DRYS) dropped about 5% on Wednesday to post a new 52-week low of $3.45 against a 52-week high of $278.40 and a Tuesday close of $3.63. Volume of about 7.8 million was less than 10% above the daily average of around 7.3 million. The dry bulk shipper closed a new $200 million revolving credit facility on Tuesday.

Emergent Capital Inc. (NYSE: EMG) dropped about 48% on Wednesday to post a new 52-week low of $0.68 after closing at $1.32 on Tuesday. The stock’s 52-week high is $4.59. Volume was more than 35 times the daily average of around 150,000 shares. The company amended its revolving credit facility on Tuesday.

Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)

Take the quiz below to get matched with a financial advisor today.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Take the retirement quiz right here.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.